Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
Phase 1
Completed
- Conditions
- Pachyonychia Congenita
- Interventions
- Drug: 1% sirolimus cream (TD201 1%)
- First Posted Date
- 2014-06-02
- Last Posted Date
- 2016-10-07
- Lead Sponsor
- TransDerm, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT02152007
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
News
No news found